Newsfiscal.ai
Phathom Pharmaceuticals Announces FDA Public Docket and Litigation Intervention Regarding VOQUEZNA
· Published
Article summary
Phathom Pharmaceuticals reported that the FDA has opened a public docket to solicit comments on regulatory issues related to an ANDA for VOQUEZNA, while the company has also intervened in ongoing litigation.
An excerpt from the original article.
Comments —
Loading comments…